By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Allergan Inc. 

2525 Dupont Drive

Irvine  California  92612  U.S.A.
Phone: 714-246-4500 Fax: n/a


Allergan is a multi-specialty health care company established more than 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meaningful treatments to help people reach their life’s potential. Today, we have approximately 11,100 highly dedicated and talented employees, global marketing and sales capabilities with a presence in more than 100 countries, a rich and ever-evolving portfolio of pharmaceuticals, biologics, medical devices and over-the-counter consumer products, and state-of-the-art resources in R&D, manufacturing and safety surveillance that help millions of patients see more clearly, move more freely and express themselves more fully. For the year ending 2012, our total product net sales totaled $5.5 billion, a 10 percent increase over 2011. From our beginnings as an eye care company to our focus today on several medical specialties, including eye care, neurosciences, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention and urologics, Allergan is proud to celebrate more than six decades of medical advances and proud to support the patients and physicians who rely on our products and the employees and communities in which we live and work. For more information regarding Allergan, go to:

Key Statistics

Ownership: Public

Web Site: Allergan
Employees: 11,100
Symbol: AGN



Elan Pharmaceuticals 

CeNes Pharmaceuticals (U.S.) 

PanVera LLC 

Pharmagene Laboratories Limited  Phase ZERO(TM) products and services.

Acadia  Discovery of alpha adrenergic drug candidates that may represent a significant breakthrough in the treatment of neuropathic pain.

Acadia  Develop and commercialize selective muscarinic drugs for the treatment of glaucoma.

Acadia  The third collaboration is designed to leverage ACADIA's R&D platform to discover and develop new therapeutics predominantly in the area of pain.

Company News
Allergan (AGN) Reaches Settlement With New York Attorney General's Office In Memantine Immediate Release Litigation 11/25/2015 10:13:26 AM
Morgan Lewis Serves As Lead U.S. Antitrust Counsel To Pfizer (PFE) In Blockbuster Combination With Allergan (AGN) 11/25/2015 7:39:53 AM
Allergan (AGN) And Rugen Therapeutics Announce Collaboration To Discover And Develop Ground-Breaking Medicines To Treat Autism Spectrum Disorders And Obsessive-Compulsive Disorders 11/25/2015 6:22:07 AM
Why the Union of Pfizer (PFE)-Allergan (AGN) May Not Lead to New Drugs 11/25/2015 6:17:52 AM
As Pfizer (PFE)-Allergan (AGN) Marry, Already Planning the Divorce 11/24/2015 6:24:04 AM
Pfizer (PFE), Allergan (AGN) Merger Could Result in More Than 10,000 Layoffs, Analyst Says 11/23/2015 2:43:17 PM
Pfizer (PFE) Marries Allergan (AGN) in $160 Billion Deal With Pfizer’s Read to Stay as CEO and Chairman 11/23/2015 5:47:38 AM
Pfizer (PFE)-Allergan (AGN) Talks About a $3-4.5 Billion Break-Up Fee, Making Allergan the Buyer Instead 11/20/2015 6:18:22 AM
Pfizer (PFE) Rumored to Pay Up to $150 Billion for Allergan (AGN) in Record-Breaking Deal 11/19/2015 5:49:41 AM
Third Point's Dan Loeb Talks Up An Amgen (AMGN)-Allergan (AGN) Merger 11/18/2015 6:17:18 AM